<VariationArchive VariationID="3068908" VariationName="NC_000004.11:g.(149041440_149073619)_(149116014_149181129)del" VariationType="Deletion" Accession="VCV003068908" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-05-12" DateCreated="2024-04-15" MostRecentSubmission="2024-04-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3228233" VariationID="3068908">
      <GeneList>
        <Gene Symbol="NR3C2" FullName="nuclear receptor subfamily 3 group C member 2" GeneID="4306" HGNC_ID="HGNC:7979" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>4q31.23</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="148078764" stop="148445508" display_start="148078764" display_stop="148445508" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" start="148999914" stop="149363671" display_start="148999914" display_stop="149363671" Strand="-" />
          </Location>
          <OMIM>600983</OMIM>
          <Haploinsufficiency last_evaluated="2020-04-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NR3C2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-04-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NR3C2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NC_000004.11:g.(149041440_149073619)_(149116014_149181129)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>4q31.23</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" outerStart="149041440" innerStart="149073619" innerStop="149116014" outerStop="149181129" display_start="149041440" display_stop="149181129" variantLength="139690" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000004.11" sequenceAccession="NC_000004" sequenceVersion="11" change="g.(149041440_149073619)_(149116014_149181129)del" Assembly="GRCh37">
            <Expression>NC_000004.11:g.(149041440_149073619)_(149116014_149181129)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000004.11:g.(149041440_149073619)_(149116014_149181129)del AND NR3C2-related disorder" Accession="RCV003994968" Version="1">
        <ClassifiedConditionList TraitSetID="97075">
          <ClassifiedCondition>NR3C2-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-02-06" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-02-06" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-04-15" MostRecentSubmission="2024-04-15">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="97075" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="76256" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">NR3C2-Related Disorders</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">NR3C2-related disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">NR3C2-related condition</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="8998304" SubmissionDate="2024-04-03" DateLastUpdated="2024-04-15" DateCreated="2024-04-15">
        <ClinVarSubmissionID localKey="NC_000004.11:g.(149041440_149073619)_(149116014_149181129)del|NR3C2-Related Disorders" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004813709" DateUpdated="2024-04-15" DateCreated="2024-04-15" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-02-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Variant summary: The variant involves the deletion of exons 4-6 in the NR3C2 gene. A presumed nomenclature of c.(1897+1_1898-1)_(2510+1_2511-1)del has been designated for the purposes of this classification. This Copy Number Variant (CNV) is expected to alter the reading frame and is predicted to result in a truncation or absence of the encoded protein due to nonsense mediated decay (NMD). The variant was absent in 21694 control chromosomes (gnomAD, structural variants dataset). To our knowledge, no occurrence of c.(1897+1_1898-1)_(2510+1_2511-1)del in individuals affected with NR3C2-Related Disorders and no experimental evidence demonstrating its impact on protein function have been reported. No submitters have cited clinical-significance assessments for this variant to ClinVar. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NR3C2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000004.11:g.(149041440_149073619)_(149116014_149181129)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">NR3C2-Related Disorders</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14342304</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8998304" TraitType="Disease" MappingType="Name" MappingValue="NR3C2-Related Disorders" MappingRef="Preferred">
        <MedGen CUI="None" Name="NR3C2-related disorder" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

